当前位置: X-MOL 学术Microb. Drug Resist. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Evaluation of the Novodiag CarbaR+, a Novel Integrated Sample to Result Platform for the Multiplex Qualitative Detection of Carbapenem and Colistin Resistance Markers
Microbial Drug Resistance ( IF 2.3 ) Pub Date : 2021-02-01 , DOI: 10.1089/mdr.2020.0132
Delphine Girlich 1, 2 , Pierre Bogaerts 3 , Warda Bouchahrouf 3 , Sandrine Bernabeu 1, 2, 4, 5 , Isabelle Langlois 4 , Christine Begasse 4 , Nicolas Arangia 4 , Laurent Dortet 1, 2, 4, 5 , Te-Din Huang 3 , Youri Glupczynski 3 , Thierry Naas 1, 2, 4, 5
Affiliation  

Objectives: This study evaluated the performance of the Novodiag® CarbaR+ an automated qualitative nucleic acid-based diagnostic assay detecting the blaVIM, blaNDM, blaIMP, blaOXA-48, blaKPC, blaOXA-23, blaOXA-58, blaOXA-24, and ISAba1 associated blaOXA-51 carbapenemase genes and colistin resistance mcr-1 gene from clinical isolates or directly from rectal swabs.

中文翻译:

Novodiag CarbaR+ 的评估,这是一种用于碳青霉烯类和粘菌素抗性标志物多重定性检测的新型集成样品到结果平台

目标:本研究评估了 Novodiag ® CarbaR+的性能,这是一种基于核酸的自动定性诊断分析,可检测bla VIM bla NDM bla IMP bla OXA-48 bla KPC bla OXA-23 bla OXA-58 bla OXA-24和 IS Aba 1 相关的bla OXA-51碳青霉烯酶基因和粘菌素抗性mcr-1基因来自临床分离株或直接来自直肠拭子。
更新日期:2021-02-04
down
wechat
bug